• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	BIOREGENX, INC. (FDIT)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Total Assets			410,986$	1,167,764$	1,150,558$	482,623$	508,535$	17,361,364$	17,890,868$	18,619,986$	865,750$				59,149$
Total Current Assets			251,265$	273,156$	249,573$	294,261$	307,796$	371,039$	326,077$	485,464$	652,664$				676$
Cash and Cash Equivalents						83,625$	58,404$	70,081$	57,395$	114,158$	125,402$
Receivables
Other Current Assets				49,057$	42,611$	53,880$	118,143$	73,319$	108,653$	93,032$	142,685$			142,685$
Assets Held for Sale in Short Term
Total Noncurrent Assets			159,721$	894,608$	900,985$	188,362$	200,739$	16,990,325$	17,564,791$	18,134,522$	213,086$				58,473$
Goodwill								7,105,522$	7,105,522$	7,105,522$
Other Intangible Assets				725,000$	725,000$			9,671,687$	10,233,776$	17,061,726$	282,960$				37,473$
Physical Assets			159,721$	169,608$	175,985$	188,362$	200,739$	213,116$	225,493$	233,135$	13,723$
Other Noncurrent Assets										101$	150,000$
Assets Held for Sale in Long Term
Total Liabilities			4,948,240$	4,814,900$	4,805,266$	4,041,547$	3,887,794$	3,800,594$	3,669,632$	3,534,687$	2,937,177$				260,691$
Total Current Liabilities			4,066,415$	3,933,831$	3,925,519$	3,784,327$	3,633,188$	3,518,334$	3,420,033$	3,384,687$	2,787,177$				64,880$
Accounts Payable			615,990$	459,652$	568,799$	490,796$	427,478$	492,713$	431,810$	370,857$	241,695$
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities
Total Noncurrent Liabilities			881,825$	881,069$	879,747$	257,220$	254,606$	282,260$	249,599$	150,000$	150,000$				195,811$
Long Term Debt			181,825$				254,606$			550,000$	200,000$				195,811$
Long Term Capital Lease Obligations
Other Noncurrent Liabilities
Total Equity			(4,537,254$)	(3,647,136$)	(3,654,708$)	(3,558,924$)	(3,379,259$)	13,560,770$	14,221,236$	15,085,299$	(2,071,427$)	(2,798,005$)	(2,580,662$)	(2,415,246$)	(2,527,938$)
Equity to Minority
Equity to Common Shareholders			(4,537,254$)	(3,647,136$)	(3,654,708$)	(3,558,924$)	(3,379,259$)	13,560,770$	14,221,236$	15,085,299$	(2,071,427$)	(2,798,005$)	(2,580,662$)	(2,415,246$)	(2,527,938$)
Additional Paid-In Capital			31,609,289$	31,488,626$	31,408,548$	31,319,653$	30,965,084$	29,777,603$	30,040,648$	29,799,102$	9,676,656$				2,436,513$
Retained Earnings			(37,115,564$)	(36,097,759$)	(36,017,194$)	(35,838,849$)	(35,571,995$)	(17,171,424$)	(16,776,564$)	(15,670,436$)	(12,517,978$)				(2,917,700$)
Treasury Stock
Capital Lease Obligations

Copy Table ✓